Plasminogen activator inhibitor type-1 deficiency attenuates murine antigen-induced arthritis

Rheumatology

Volumn 41, Issue 2, 2002, Pages 136-141

  Van Ness, K ^a   Chobaz Peclat V ^a   Castellucci, M ^b   So, A ^a   Busso, N ^a  

^a LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^b UNIVERSITÀ POLITECNICA DELLE MARCHE   (Italy)

Author keywords

Fibrin; Fibrinolysis; Inflammation; Mice; PAI 1; Rheumatoid arthritis

Indexed keywords

ANTIGEN; D DIMER; DYE; FIBRIN; FIBRIN DEGRADATION PRODUCT; PLASMIN; PLASMINOGEN ACTIVATOR; PLASMINOGEN ACTIVATOR INHIBITOR 1; TECHNETIUM 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTHRITIS; ARTICLE; ARTICULAR CARTILAGE; CONTROLLED STUDY; DISEASE SEVERITY; ENZYME ACTIVITY; FIBRIN DEPOSITION; FIBRINOLYSIS; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; KNEE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; SCORING SYSTEM; STAINING; SYNOVITIS; WILD TYPE; ZYMOGRAPHY;

EID: 0036100401     PISSN: 14620324     EISSN: None     Source Type: Journal    
DOI: 10.1093/rheumatology/41.2.136     Document Type: Article

References (26)

1. Etiology and pathogenesis of rheumatoid arthritis
2. Fibrin: Metabolism, immunopathogenesis and significance in rheumatoid arthritis
3. Linkage between inflammation and coagulation: An update on the molecular basis of the crosstalk
4. Extravascular fibrin formation and dissolution in synovial tissue of patients with osteoarthritis and rheumatoid arthritis
5. Fibrin-specific fibrinolysis
6. The plasminogen activator/plasmin system
7. Of mice and men. The function of plasminogen activator inhibitors (PAIs) in vivo
8. Plasminogen activation in synovial tissues: Differences between normal, osteoarthritis, and rheumatoid arthritis joints
9. Enhanced expression of genes involved in coagulation and fibrinolysis in murine arthritis
10. Fibrin degradation in the synovial fluid of rheumatoid arthritis patients: A model for extravascular fibrinolysis
11. Mobilization of fibrinolytic enzymes in synovial fluid and plasma of rheumatoid arthritis and spondylo-arthropathy and their relation to radiological destruction
12. Plasmin and plasminogen activator inhibitor type 1 promote cellular motility by regulating the interaction between the urokinase receptor and vitronectin
13. Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization
14. Bone matrix degradation by the plasminogen activation system. Possible mechanism of bone destruction in arthritis
15. Cartilage degradation and invasion by rheumatoid synovial fibroblasts is inhibited by gene transfer of a cell surface-targeted plasmin inhibitor
16. Exacerbation of antigen-induced arthritis in urokinase-deficient mice
17. Plasminogen activator inhibitor-1 gene-deficient mice. I. Generation by homologous recombination and characterization
18. Antigen-induced arthritis in mice. I. Induction of arthritis in various strains of mice
19. Detection and quantification of experimental joint inflammation in mice by measurement of 99mTc-pertechnetate uptake
20. Invasion marker PAI-1 remains a strong prognostic factor after long-term follow-up both for primary breast cancer and following first relapse
21. Cancer. Proteases-invasion and more
22. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury
23. Bleomycin-induced pulmonary fibrosis in transgenic mice that either lack or overexpress the murine plasminogen activator inhibitor-1 gene
24. Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis
25. Impaired wound healing in mice with a disrupted plasminogen gene
26. Imbalance of tissue-type plasminogen activator (t-PA) and its specific inhibitor (PAI-1) in patients with rheumatoid arthritis associated with disease activity